Literature DB >> 23738182

Asymptomatic bone cement pulmonary embolism after vertebroplasty: case report and literature review.

Girolamo Geraci1, Giorgio Lo Iacono, Chiara Lo Nigro, Fabio Cannizzaro, Massimo Cajozzo, Giuseppe Modica.   

Abstract

Introduction. Acrylic cement pulmonary embolism is a potentially serious complication following vertebroplasty. Case Report. A 70-year-old male patient was treated with percutaneous vertebroplasty for osteoporotic nontraumatic vertebral collapse of L5-S1. Asymptomatic pulmonary cement embolism was detected on routine postoperative chest radiogram and the patient was treated with enoxaparin, amoxicillin, and dexamethasone. At the followup CT scan no further migration of any cement material was reported; and the course was uneventful. Discussion. The frequency of local leakage of bone cement is relatively high (about 80-90%), moreover, the rate of cement leakage into the perivertebral veins (seen in up to 24% of vertebral bodies treated) with consequent pulmonary cement embolism varies from 4.6 to 6.8% (up to 26% in radiologic studies); the risk of embolism is increased with the liquid consistency of the cement and with the treatment of some malignant lesions. Patients may remain asymptomatic and develop no known long-term sequelae. Conclusions. Our ancedotal case illustrates the need for close monitoring of patients undergoing percutaneous vertebroplasty and emphasizes the importance of prompt and correct diagnosis and treatment, even if actually there is no agreement regarding the therapeutic strategy.

Entities:  

Year:  2013        PMID: 23738182      PMCID: PMC3662203          DOI: 10.1155/2013/591432

Source DB:  PubMed          Journal:  Case Rep Surg


1. Introduction

Bone cement embolism is a severe and potentially life-threatening complication of cement (polymethylmethacrylate, PMM) vertebroplasty. We report a case of asymptomatic PMM pulmonary embolism following a surgical vertebroplasty.

2. Case Report

A 70-year-old male patient with a complex medical history of coronary heart disease and hypertension (bicameral pace-maker dependent, left carotid artery stent, and triple aortocoronary bypass) was admitted to our university hospital for osteoporotic nontraumatic vertebral collapse of L5-S1 and spondylotic degeneration of vertebral bodies. Preoperative serum chemistries and electrocardiogram were normal. The patient was in a prone position and percutaneous vertebroplasty was performed with a 10-gauge needle, under biplane fluoroscopic control with unilateral transpedicular approach. Bone cement was classically prepared at 24°C by mixing 30 mL of the PMM powder with 2 g of sterile barium sulfate powder for opacification and 1 g of powdered antibiotic, before adding 10 mL of the liquid monomer; cement injection was monitored on continuous fluoroscopy in the lateral plane with intermittent evaluation in anteroposterior projection to detect early lateral venous leaks. When cement was visualized in the posterior fourth of the vertebral body or beyond the confines of the vertebral body, the procedure was terminated. Postoperative serum chemistries, arterial blood gas, and cardiac enzymes were normal, and the postoperative course was uneventful. Pulmonary cement embolism was detected on routine postoperative chest radiograph (Figure 1, cement leakage into the Batson's paravertebral venous system) and confirmed with chest computed tomography (Figures 2(a) and 2(b)).
Figure 1

Cement leakage into the Batson's paravertebral venous system.

Figure 2

(a) Cement leakage into the Batson's paravertebral venous system. (b) Pulmonary embolism (arrow: presence of cement in the subsegmentary and segmentary pulmonary arteries of the right superior lobe).

Thoracic CT revealed the characteristic appearance of cement leakage at the level of the vertebroplasty in the perivertebral venous system, draining into juxtarenal inferior cava vein, partially obstructed by the same material, and into the azygos system between D9 and L2; the presence of cement in the subsegmentary and segmentary pulmonary arteries of the right superior lobe confirmed a pulmonary microembolism (centimetric areas of shaded ground glass) caused by cement. The patient was treated with anticoagulants (enoxaparin 4000 IU a day), antibiotics (Amoxicillin 2 g a day), and corticosteroids (dexamethasone 4 mg a day) and responded favorably. Prior to discharge on postoperative day 4, a repeat CT scan showed no substantial change in the distribution of the cement. Therefore, he was discharged home on oral warfarin for chronic anticoagulation (to reduce the risk of thrombosis on the cement remaining in the distal part of the arterial pulmonary tree), and monthly follow up was scheduled. The followup CT scan showed no further migration of any cement material. Furthermore, no foreign material was identified within the right atrium-internal vena cava junction (Figure 3).
Figure 3

Normal followup CT scan.

3. Discussion

Bone cement has been widely used in orthopaedic procedure and neurosurgery since 1987: PMM cement, a rapidly setting bone cement, is injected using a transpedicular or paravertebral approach, under fluoroscopic guidance [1]. Although percutaneous vertebroplasty is a relatively safe, simple, and commonly performed procedure for the management of vertebral compression fractures, it can be associated with fatal complications, such as spinal cord compression resulting in paraplegia, cerebral embolism, penetration of the right ventricle, renal artery embolism, and acute respiratory distress syndrome [2]; minor complications, reported in large series, were rare, local, and temporary and included infection, radicular pain, and spinal cord compression; moreover, most complications involved transitory worsening of pain or chest discomfort, dyspnea, and fever [3]; these symptoms may also lead to cardiovascular collapse and, rarely, to death. The frequency of local leakage of bone cement is relatively high (about 80–90%); moreover, the rate of cement leakage into the perivertebral veins (seen in up to 24% of vertebral bodies treated) with consequent pulmonary cement embolism varies from 4.6 to 6.8% (up to 26% in radiologic studies): the risk is increased with liquid consistency of the PMM and with the treatment of some malignant lesions because of the more frequent cortical destruction of the vertebral body and higher vascularization associated with some malignant tumors; pulmonary embolism is attributable to the passage of the PMM into the perivertebral veins and from there into the azygos vein and the inferior vena cava, to end up in the pulmonary vasculature [3-7]. Otherwise, more reviews in the literature published specifically report with no case of cement pulmonary embolism despite the significant numbers of cement leaks into the venous system (Table 1).
Table 1

Case reports and series of patients with asymptomatic pulmonary embolism after vertebroplasty, from PubMed database, queries: “complication of vertebroplasty,” “bone cement pulmonary embolism” (modified and ampliated from [7]).

AuthorsNo. of asymptomatic pulmonary embolismProcedure and indicationsTherapy
Grados et al., 2000 [10]1/40 (2.5%)PVP, osteoporotic fractureNot reported
Bernhard et al., 2003 [11]1PVP, osteoporotic fractureNot reported
Pleser et al., 2004 [12]1PVP, osteoporotic fractureHeparin + warfarin for 6 months
Seo et al., 2005 [13]1PVP, osteoporotic fractureOperative embolectomy
Baumann et al., 2006 [14]1PVP, osteoporotic fractureWarfarin for 3 months
Freitag et al., 2006 [15]1PVP, osteoporotic fractureWarfarin for 6 months
MacTaggart et al., 2006 [16]1PVP, osteoporotic fractureNot reported
Neuwirth et al., 2006 [17]1PVP, osteoporotic fractureNot reported
Walz et al., 2006 [18]1/57 (2%)PVP, osteoporotic fractureNo anticoagulation
Quesada and Mutlu, 2006 [19]1PVP, osteoporotic fractureNot reported
Abdul-Jalil et al., 2007 [20]1PVP, osteoporotic fractureLow dose heparin
Serra et al., 2007 [21]3/175 (2%)PVP, osteoporotic fractureNot reported
Schneider and Plit, 2007 [22]1PVP, osteoporotic fractureNot reported
Yeo et al., 2009 [23]18/119 (15%)PVP, osteoporotic fractureNot reported
Venmans et al., 2008 [24]11/299 (3%)PVP, osteoporotic fractureNot reported
Venmans et al., 2010 [25]14/54 (26%)PVP, variousNot reported
Fornell-Pérez et al., 2010 [26]1PVP, osteoporotic fractureClinical observation
Nesnídal et al., 2010 [27]1PVP, osteoporotic fractureClinical observation
Dash and Brinster, 2011 [2]1PVP, osteoporotic fractureOpen heart surgery
Luetmer et al., 2011 [28]22/244 (9%)PVP, various Clinical observation
Tourtier and Cottez, 2012 [29]1PVP, osteoporotic fractureClinical observation

Total84 casesPVP, osteoporoticfracture (100%)47% not reported 19% clinical observation 9% warfarin alone 5% heparin alone 5% heparin + warfarin 5% open heart surgery 5% embolectomy 5% no anticoagulation

PVP: percutaneous vertebroplasty.

Patients may remain asymptomatic and develop no known long-term sequelae (when cement emboli are encountered in an asymptomatic patient, they are probably of no clinical significance and have no known long-term sequelae). However, when emboli are discovered incidentally on a conventional chest radiograph, their suggestive appearance is a high-density opacity in a tubular branching pattern, corresponding to pulmonary arterial distribution [3, 8]. Some authors reported the use of a preinjection venogram to decrease the incidence of pulmonary embolism, and the injection of sclerosing agents into the vertebral body before vertebroplasty has also been suggested to close venous channels [2, 7]. The treatment for symptomatic or central pulmonary cement embolism is surgical embolectomy, or, in selected cases, percutaneous removal, whereas more conservative management with anticoagulants, antibiotics, and corticosteroid is reserved for smaller or peripherally located emboli [3, 9]: anticoagulation therapy reduces the risk of thrombus formation on the embolic material but cannot reduce the right ventricle afterload and cannot improve the pulmonary ventilation-perfusion ratio, which is the cause of respiratory failure.

4. Conclusions

This case allows us to conclude that the risk of pulmonary embolism of PMM might be underestimated. We confirm the necessity of routine chest radiograph following every vertebroplasty in order to detect pulmonary PMM embolism and thereby prevent serious delayed cardiopulmonary failures. From our brief literature review, it is clear that no agreement has been reached regarding the therapeutic strategy to be used for pulmonary embolism caused by cement, especially in asymptomatic patients, varying from clinical followup to combined heparin plus warfarin. Surely, pulmonary embolectomy is a therapeutic tool in critical patients and appears to be a reliable and effective procedure in cases of severe respiratory and cardiac failure due to acrylic cement embolism in the main pulmonary trunks because it is the only treatment that could provide complete recovery from pulmonary and cardiac failure. Anticoagulants appear to have been effective in preventing pulmonary infarction and improving clinical course although it is imprudent to recommend any therapeutic approach based on a single case.
  28 in total

Review 1.  Percutaneous vertebroplasty: a developing standard of care for vertebral compression fractures.

Authors:  J M Mathis; J D Barr; S M Belkoff; M S Barr; M E Jensen; H Deramond
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Asymptomatic diffuse pulmonary embolism caused by acrylic cement: an unusual complication of percutaneous vertebroplasty.

Authors:  J Bernhard; P F Heini; P M Villiger
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Images in clinical medicine. Pulmonary cement embolism after vertebroplasty.

Authors:  Jean-Pierre Tourtier; Sophie Cottez
Journal:  N Engl J Med       Date:  2012-01-19       Impact factor: 91.245

4.  [Multiple pulmonary embolisms caused by acrylic cement after vertebroplasty].

Authors:  Roberto Fornell-Pérez; José Manuel Santana-Montesdeoca; Paula Junquera-Rionda
Journal:  Arch Bronconeumol       Date:  2010-08-01       Impact factor: 4.872

5.  CT evaluation of local leakage of bone cement after percutaneous kyphoplasty and vertebroplasty.

Authors:  In Jae Lee; A Lam Choi; Mi-Yeon Yie; Ji Young Yoon; Eui Yong Jeon; Sung Hye Koh; Dae Young Yoon; Kyung Ja Lim; Hyoung June Im
Journal:  Acta Radiol       Date:  2010-07       Impact factor: 1.990

6.  [CT-based analysis of cement distribution in unipedicular vertebroplasty].

Authors:  M Walz; E Esmer; B Kolbow
Journal:  Unfallchirurg       Date:  2006-11       Impact factor: 1.000

Review 7.  Acrylic cement pulmonary embolus masquerading as an embolized central venous catheter fragment.

Authors:  Jason N MacTaggart; Iraklis I Pipinos; Jason M Johanning; Thomas G Lynch
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

8.  Management of pulmonary embolism during acrylic vertebroplasty.

Authors:  Piergiorgio Tozzi; Yasmine Abdelmoumene; Antonio F Corno; Philip A Gersbach; Henri-Marcel Hoogewoud; Ludwig K von Segesser
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

9.  Frequency and outcome of pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty.

Authors:  A Venmans; P N M Lohle; W J van Rooij; H J J Verhaar; W P Th M Mali
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

10.  Pulmonary cement embolism after percutaneous vertebroplasty in osteoporotic vertebral compression fractures: incidence, characteristics, and risk factors.

Authors:  Yeo Ju Kim; Joon Woo Lee; Kun Woo Park; Jin-Seob Yeom; Hee Sun Jeong; Jeong Mi Park; Heung Sik Kang
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

View more
  15 in total

Review 1.  Complications in musculoskeletal intervention: important considerations.

Authors:  David T Wang; Melissa Dubois; Sean M Tutton
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Risk factors for bone cement leakage in percutaneous vertebroplasty: a retrospective study of four hundred and eighty five patients.

Authors:  Si-Yuan Zhu; Zhao-Ming Zhong; Qian Wu; Jian-Ting Chen
Journal:  Int Orthop       Date:  2016-01-12       Impact factor: 3.075

3.  Intracardiac cement embolism during percutaneous vertebroplasty: incidence, risk factors and clinical management.

Authors:  Sarah Fadili Hassani; Evelyne Cormier; Eimad Shotar; Mehdi Drir; Jean-Philippe Spano; Laetitia Morardet; Jean-Philippe Collet; Jacques Chiras; Frédéric Clarençon
Journal:  Eur Radiol       Date:  2018-07-27       Impact factor: 5.315

4.  Retrograde Flow Cement Leakage during Kyphoplasty.

Authors:  Kalliopi Alpantaki; Christos Koutserimpas; Nikolaos-Achilleas Arkoudis; Alexander Hadjiapavlou
Journal:  Maedica (Bucur)       Date:  2022-03

5.  Cement leakage and complication of liposarcoma spinal metastasis during vertebral augmentation procedure: a case report.

Authors:  Aykut Akpinar; Necati Ucler; Cem Seyho Yucetas; Uzay Erdogan; Mehmet Davut Ucar
Journal:  J Med Case Rep       Date:  2016-02-24

6.  Embolization of prostatic brachytherapy seeds to pulmonary arteries: a case study.

Authors:  Alexander D Calvert; Andrew W Dyer; Van A Montgomery
Journal:  Radiol Case Rep       Date:  2016-11-12

7.  Pulmonary Artery Cement Embolism after a Vertebroplasty.

Authors:  Anas Nooh; Fahad H Abduljabbar; Ahmed H Abduljabbar; Peter Jarzem
Journal:  Case Rep Orthop       Date:  2015-06-28

8.  Acute right atrial and pulmonary artery bone cement mass emboli following vertebroplasty.

Authors:  Mohammad S Diab; Amr Diab; Walid Dihmis; Samir Diab
Journal:  JRSM Open       Date:  2016-06-06

9.  Complications of percutaneous vertebroplasty: An analysis of 1100 procedures performed in 616 patients.

Authors:  Agnieszka Saracen; Zbigniew Kotwica
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  The Effect of TBB, as an Initiator, on the Biological Compatibility of PMMA/MMA Bone Cement.

Authors:  Kosuke Hamajima; Ryotaro Ozawa; Juri Saruta; Makiko Saita; Hiroaki Kitajima; Samira Rahim Taleghani; Dan Usami; Donya Goharian; Mitsunori Uno; Ken Miyazawa; Shigemi Goto; Keiichi Tsukinoki; Takahiro Ogawa
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.